BHI News Section Archives - Page 78 of 1201

News

September 14, 2023

Federal Trade Commission allows Amgen’s $27.8 billion acquisition of Horizon Therapeutics

THOUSAND OAKS, Calif. and DUBLIN, Sept. 1, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Horizon Therapeutics plc (NASDAQ:HZNP) today announced the entry into a consent order agreement with the Federal…

Andy

Love0

News

September 13, 2023

5 Excellent Finalists Chosen for the 8th Annual BHCR Crab Trap

Rockville, Maryland – September 13, 2023 – BioHealth Innovation, Inc. (BHI), a leading regional innovation intermediary, is thrilled to announce…

Andy

Love0

News

September 13, 2023

Accelerate Investor Conference Returns to Showcase Leading Early-Stage Companies to National Investors

ARLINGTON, Va.--(BUSINESS WIRE)--The Accelerate Investor Conference is back for its third year at George Mason University’s Arlington Campus, November 1-2, 2023.…

Andy

Love0

News

September 13, 2023

Gain Therapeutics Receives Approval to Commence Phase 1 Clinical Study of GT-02287 from the Human Research Ethics Committee (HREC) in Australia

BETHESDA, Md., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company…

Andy

Love0

News

September 13, 2023

Altimmune Announces Completion of Dosing in the Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or Overweight

GAITHERSBURG, Md., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the completion…

Andy

Love0

News

September 11, 2023

NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen

BELTSVILLE, Md., Sept. 07, 2023 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel,…

Andy

Love0

News

September 11, 2023

Rockville’s Supernus Announces New Qelbree® Data Showing Improvement in ADHD Symptoms

ROCKVILLE, Md., Sept. 09, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and…

Andy

Love0

News

September 11, 2023

REGISTER NOW – The 9th Annual BioHealth Capital Region Forum: A Week Away and a World of Opportunity

One week away from the 9th Annual BioHealth Capital Region Forum (https://bit.ly/BHCRForum2023), a cornerstone event for anyone involved in the…

Andy

Love0

News

September 6, 2023

Adaptive Phage Therapeutics CEO Greg Merril and His Father’s Journey Highlighted in BBC StoryWorks’ Documentary, ‘Race Against Resistance’

The documentary-style film addresses the urgent global health crisis of antimicrobial resistance, which is causing widespread concern in the scientific…

Andy

Love0

News

September 5, 2023

Seize Opportunities at the 6th Annual BioHealth Capital Region Investment Conference: Applications Due September 12th

Your Invitation to apply to a Key Investment Event in Rockville, Maryland Awaits There's still time if you haven't yet…

Andy

Love0

BHI News Section

Federal Trade Commission allows Amgen’s $27.8 billion acquisition of Horizon Therapeutics

5 Excellent Finalists Chosen for the 8th Annual BHCR Crab Trap

Accelerate Investor Conference Returns to Showcase Leading Early-Stage Companies to National Investors

Gain Therapeutics Receives Approval to Commence Phase 1 Clinical Study of GT-02287 from the Human Research Ethics Committee (HREC) in Australia

Altimmune Announces Completion of Dosing in the Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or Overweight

NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen

Rockville’s Supernus Announces New Qelbree® Data Showing Improvement in ADHD Symptoms

REGISTER NOW – The 9th Annual BioHealth Capital Region Forum: A Week Away and a World of Opportunity

Adaptive Phage Therapeutics CEO Greg Merril and His Father’s Journey Highlighted in BBC StoryWorks’ Documentary, ‘Race Against Resistance’

Seize Opportunities at the 6th Annual BioHealth Capital Region Investment Conference: Applications Due September 12th

About BioHealth Innovation

Contact

Connect

BHI News Section

About BioHealth Innovation

Contact

Connect

Search